Rottendorf Pharma
Dr. Kerstin Schultenkämper started their professional career as a Biologisch-Technische Assistentin at Eurofins Inlab GmbH from November 2011 to October 2012. Dr. Kerstin then pursued their PHD at Bielefeld University, where they worked as a PHD Student from January 2018 to February 2021. Currently, they are employed as a QA-Manager at Rottendorf Pharma since May 2021.
Dr. Kerstin Schultenkämper began their education in 2008 at Carl-Severing-Berufskolleg Bielefeld, where they pursued a dual apprenticeship in Biomedical Science, eventually earning their General University Entrance Qualification (Allgemeine Hochschulreife) in 2011. Dr. Kerstin then went on to Bielefeld University, where they obtained a Bachelor of Science degree (BS) in Biology in 2015. Continuing their studies at the same institution, Dr. Schultenkämper earned a Master of Science degree (MS) in Genomic Systems Biology in 2017.
Note: It is not provided whether Dr. Schultenkämper completed any further education beyond their Master's degree.
This person is not in any offices
Rottendorf Pharma
1 followers
A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 85 years. The company produces more than 600 originator and generic drug products annually for big, small, virtual, and global pharmaceutical and biotechnology companies. Rottendorf Pharma operates by the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), in which we work as an extension of clients' organizations. Therefore leveraging our expertise to optimize solid dosage form production for our customers' benefit. Rottendorf Pharma has neither their own product brands in the market nor holds any product licenses, and therefore is never in competition with their clients.